TROV

TrovaGene, Inc. Press Releases

$4.45
*  
0.24
5.12%
Get TROV Alerts
*Delayed - data as of Nov. 26, 2014  -  Find a broker to begin trading TROV now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Trovagene to Present at 26th Annual Piper Jaffray Healthcare Conference
11/26/2014 9:05:00 AM - PR Newswire


Trovagene to Present at 26th Annual Piper Jaffray Healthcare Conference
11/26/2014 9:05:00 AM - PR Newswire


Trovagene Releases Clinical Study Results for the Detection and Monitoring of KRAS Mutations in Circulating Tumor DNA of Colorectal Cancer Patients
11/20/2014 9:08:00 AM - PR Newswire


Trovagene to Present at Upcoming Healthcare Conferences
11/12/2014 8:15:00 AM - PR Newswire
▼-7.68 % Price Change since this news event. The Volume Ratio is 2.73.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Trovagene, Inc. Announces Third Quarter 2014 Financial Results
11/6/2014 4:05:00 PM - PR Newswire
▼-3.68 % Price Change since this news event. The Volume Ratio is 1.04.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Trovagene Schedules Release of Third Quarter 2014 Financial Results and Investor Conference Call
10/29/2014 8:10:00 AM - PR Newswire
▲1.37 % Price Change since this news event. The Volume Ratio is 1.03.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Clinical Study Using Trovagene''s Precision Cancer Monitoring Platform Published in Cancer Discovery
10/27/2014 8:10:00 AM - PR Newswire
▲1.83 % Price Change since this news event. The Volume Ratio is 5.94.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Trovagene to Present at 13th Annual BIO Investor Forum
10/6/2014 4:30:00 PM - PR Newswire


Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium
10/1/2014 8:05:00 AM - PR Newswire


Trovagene Expands Clinical Program with New Study Evaluating its Precision Cancer Monitoring Platform in Lung Cancer
9/29/2014 8:05:00 AM - PR Newswire


Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board
9/17/2014 8:05:00 AM - PR Newswire